ID   VDSO/CMV-8
AC   CVCL_E7E4
RX   PubMed=9563901;
CC   Characteristics: Control cell line for VDSO/E6-18 (Cellosaurus=CVCL_E7E5) and VDSO/E6-19 (Cellosaurus=CVCL_E7EA) (PubMed=9563901).
CC   Doubling time: 28 hours (PubMed=9563901).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7E3 ! VDS-0
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=9563901;
RA   Fan S.-J., Cherney B.W., Reinhold W.C., Rucker K., O'Connor P.M.;
RT   "Disruption of p53 function in immortalized human cells does not
RT   affect survival or apoptosis after taxol or vincristine treatment.";
RL   Clin. Cancer Res. 4:1047-1054(1998).
//